The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010)

Thumbnail
View/Open
Date
2017-05-08
ICR Author
Author
Bliss, J
Kernaghan, S
Fribbens, C
Stevenson, L
Morden, J
Type
Other
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/873
Collections
Subject
Science & Technology
Life Sciences & Biomedicine
Medicine, Research & Experimental
Research & Experimental Medicine
Research team
Clinical Trials & Statistics Unit
Language
eng
License start date
2017-05-08
Citation
TRIALS, 2017, 18 pp. ? - ? (1)
Publisher
BIOMED CENTRAL LTD